Amha Tadesse - Concepedia

Concepedia

Author

Amha Tadesse

United States Military Academy

Also Known As

A TADESSE, A Tadesse, A. Tadesse, A.T. Anteneh Tadesse, Abebe Tadesse, Amha S. Tadesse, Amha Tadesse

25

Publications

2.5K

Citations

16

H-Index

30

Concepts

All Affiliations

United States Military Academy Johns Hopkins University Indiana University – Purdue University Indianapolis University of New Mexico University of Washington

AT

About

Amha Tadesse is an author at United States Military Academy specializing in medicine, human papillomavirus vaccines, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	855
2	Immunology	5	5	462
3	Public Health	3	3	406
4	Epidemiology	3	3	466
5	Molecular Biology	1	1	19

Amha Tadesse

×

16

Publications

2.5K

Citations

16

H-Index

	Year	Citations
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years Darron R. Brown, Susanne K. Kjær, Kristján Sigurðsson, The Journal of Infectious Diseases	2009	627
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women Nubia Muñóz, Susanne K. Kjær, Kristján Sigurðsson, JNCI Journal of the National Cancer Institute	2010	562
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions Susanne K. Kjær, Kristján Sigurðsson, Ole‐Erik Iversen, Cancer Prevention Research GynecologyCervical Cancer PreventionContinued Prophylactic EfficacyHuman Papillomavirus VaccinesVaccine Trial	2009	324
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years Cosette M. Wheeler, Susanne K. Kjær, Kristján Sigurðsson, The Journal of Infectious Diseases	2009	241
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine Elmar A. Joura, Susanne K. Kjær, Cosette M. Wheeler, Vaccine VaccinationVaccine SafetyVaccine DevelopmentCervical CancerHuman Papillomavirus Vaccines	2008	191
Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women Kenneth H. Fife, Cosette M. Wheeler, Laura A. Koutsky, Vaccine VaccinationVaccine SafetyHuman Papillomavirus VaccinesImmunologyVaccine Testing	2004	109
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine Darron R. Brown, Kenneth H. Fife, Cosette M. Wheeler, Vaccine VaccinationVaccine DevelopmentHuman Papillomavirus VaccinesVaccine TargetImmunology	2004	88
The association of hormonal contraceptive use and HPV prevalence Morgan A. Marks, Patti E. Gravitt, Swati Gupta, International Journal of Cancer	2010	57
Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients Ilvars Silins, Elisabeth Åvall‐Lundqvist, Amha Tadesse, Gynecologic Oncology Cervical Cancer ScreeningOncologyCervical CancerCancer DetectionHuman Papillomavirus Vaccines	2002	49
Combined Oral Contraceptive Use Increases HPV Persistence but Not New HPV Detection in a Cohort of Women From Thailand Morgan A. Marks, Patti E. Gravitt, Swati Gupta, The Journal of Infectious Diseases	2011	45

Page 1